Improving prostate cancer treatment for men with HIV
Optimizing Treatment of Prostate Cancer in Men living with HIV
This study is looking at how having HIV impacts the treatment and results of prostate cancer in men with HIV, aiming to find the best ways to manage their cancer while keeping their overall health and quality of life in mind.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10895472 on NIH RePORTER |
What this research studies
This research investigates how HIV affects the treatment and outcomes of prostate cancer in men living with HIV. It aims to understand the unique challenges these patients face, including rapid cancer development and increased treatment side effects. By comparing different treatment strategies, the research seeks to identify the best approaches for managing localized prostate cancer while considering the overall health and quality of life of patients. The study will gather data to inform better decision-making for treatment options tailored to this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are men living with HIV who have been diagnosed with localized prostate cancer.
Not a fit: Patients with advanced prostate cancer or those not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatment options for prostate cancer in men living with HIV.
How similar studies have performed: While there has been limited research specifically on prostate cancer treatment in men with HIV, the study addresses a critical gap in knowledge that has not been previously explored in clinical trials.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Sigel, Keith Magnus — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sigel, Keith Magnus
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.